KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Cerence (CRNC) over the last 8 years, with Q4 2025 value amounting to $8.6 million.

  • Cerence's Gains from Investment Securities rose 219732.62% to $8.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.4 million, marking a year-over-year increase of 13262.68%. This contributed to the annual value of $6.7 million for FY2025, which is 3412.57% down from last year.
  • Cerence's Gains from Investment Securities amounted to $8.6 million in Q4 2025, which was up 219732.62% from $2.0 million recorded in Q3 2025.
  • Cerence's Gains from Investment Securities' 5-year high stood at $8.6 million during Q4 2025, with a 5-year trough of $100000.0 in Q2 2021.
  • In the last 5 years, Cerence's Gains from Investment Securities had a median value of $2.4 million in 2021 and averaged $2.6 million.
  • As far as peak fluctuations go, Cerence's Gains from Investment Securities soared by 317400.0% in 2022, and later crashed by 9411.42% in 2024.
  • Cerence's Gains from Investment Securities (Quarter) stood at $2.5 million in 2021, then rose by 0.16% to $2.5 million in 2022, then grew by 26.23% to $3.1 million in 2023, then tumbled by 87.95% to $374000.0 in 2024, then skyrocketed by 2197.33% to $8.6 million in 2025.
  • Its Gains from Investment Securities stands at $8.6 million for Q4 2025, versus $2.0 million for Q3 2025 and $100000.0 for Q2 2025.